Shugan Decoction Ameliorated WAS‐Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4 ‐ PGE 2 Signaling
Neurogastroenterology & Motility · 2025-12 · 37 (12)
DOI: 10.1111/nmo.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 22.06.2025. Verfasst von Ya Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: TRPV Cation Channels, Colon, Irritable Bowel Syndrome, Gastrointestinal Motility. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
To clarify the function of transient receptor potential vanilloid 4 (TRPV4)‐prostaglandin E2 (PGE 2 ) signaling in the colon of rats with irritable bowel syndrome (IBS) induced by water‐avoidance stress (WAS). On this basis, to explore whether colonic TRPV4‐PGE 2 signaling is involved in the mechanism of action of Chinese herbal formula Shugan Decoction (SGD) on IBS.
Methods
The rat model of IBS was induced by chronic WAS, and the number of fecal pellets was counted. Meanwhile, the visceral pain pressure threshold was measured using colorectal distension. Western blot or immunofluorescence was used to measure the protein expressions of TRPV4, EP1, and EP3 in the colon. ELISA was used to determine the contents of PGE 2 in colonic tissue. The contractile activities of the colonic longitudinal muscle strips were observed via an organ bath experiment.
Results
Compared with the control group, the content of PGE 2 , the expressions of TRPV4, EP1, and EP3 receptors in the colon of the rats in the WAS group increased, accompanied by enhanced fecal pellet output and reduced visceral pain pressure threshold; meanwhile, the tension and the amplitude of the spontaneous contraction of the colonic longitudinal muscle were significantly enhanced. These parameter values in the SGD group were significantly restored compared with those in the WAS group. The suppression of contractile tension and amplitude by the TRPV4 inhibitor HC‐067047 in the WAS group was greater than that in the control and SGD groups. The enhancement of contractile amplitude by PGE 2 in the WAS group was weaker than that in the control group but was stronger than that in the SGD group. Interestingly, the suppression of contractile tension by the EP1 antagonist ONO‐8711 in the SGD group was less than that in the WAS group.
Conclusion
SGD can ameliorate dysmotility of colonic longitudinal muscle and visceral hypersensitivity caused by WAS maybe by reducing the release of PGE 2 and decreasing the expression of TRPV4 and EP1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, Y., Zhou, C., He, Y., Wu, Y., Pan, K., Mo, L., Cai, S., & Yuan, J. (2025). Shugan Decoction Ameliorated WAS‐Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4 ‐ PGE 2 Signaling. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70104
Vancouver
Feng Y, Zhou C, He Y, Wu Y, Pan K, Mo L, et al. Shugan Decoction Ameliorated WAS‐Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4 ‐ PGE 2 Signaling. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70104
BibTeX
@article{Feng2025,
author = {Feng, Ya and Zhou, Chunyu and He, Youcheng and Wu, Yue and Pan, Keyi and Mo, Lian and Cai, Shuyu and Yuan, Jianye},
title = {Shugan Decoction Ameliorated WAS‐Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4 ‐ PGE 2 Signaling},
journal = {Neurogastroenterology & Motility},
year = {2025},
volume = {37},
number = {12},
doi = {10.1111/nmo.70104}
}
EUVIMED